Original Source(s)
Rethinking Progress in Clinical Trials
May 20, 2026
Related Content
Roswell Park Experts Report on Discovery of Rare Bladder Cells, Neural Mapping of Pelvic Floor Muscles at AUA 2026
Evidence provided by a Roswell Park study indicates that neoadjuvant chemotherapy may be the preferred course of treatment for patients with non-muscle-invasive bladder cancer (NMIBC) when their disease progresses and they are diagnosed with muscle-invasive bladder cancer (MIBC)
This Week’s Biopharma News: FDA Commissioner Steps Down
Marty Makary’s resignation puts the agency under acting leadership, while BMS and Hengrui unveil a multibillion-dollar pipeline deal and GSK lines up a chronic hepatitis B launch in China.
May 19, 2026
-
4 min
Three Trends Shaping Multi-omics Sample Preparation
Maximizing insight from limited samples, aligning data across molecular layers, and building consistency from the first step
May 19, 2026
-
4 min
